While elevated TIGIT expression has been demonstrated in human ESCC tissue samples after receiving nCRT, whether RT alone can also affect the expression of TIGIT on lymphocytes whether targeting the TIGIT/CD155 pathway enhances the efficacy of RT, and the mechanisms that underlie these phenomena remain unknown. This evidence concerns the gene PVR and esophageal squamous cell carcinoma.